Hepion Pharmaceuticals director Gary S. Stetz II files initial beneficial ownership statement
HEPA•Initial Form 3 filing
Hepion Pharmaceuticals director Gary S. Stetz II filed an initial Form 3 on July 10 for a July 1 reporting event.
Related News
Nubank quarterly net profit beats estimates, topping $1 billion for first time
NU•
CVRx COO Brent Binkowski acquires 26,223 common shares worth $76,416.58
CVRX•
Cracker Barrel files Form 3 for SVP Culinary & Menu Strategy Chad Crawford
CBRL•
Mink Brook Asset Management acquires $4,601 of DLH Holdings common shares
DLHC•
Grid Dynamics COO Yury Gryzlov disposes of 3,930 shares worth $31,440
GDYN•